We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Synchrony Financial Rides on Acquisitions, High Costs a Woe
Read MoreHide Full Article
Synchrony Financial (SYF - Free Report) offers a wide range of credit products through a diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and health and wellness providers. The company’s solid organic and inorganic strategies backed by strong financial position have paved the way for its long-term growth.
Synchrony Financial’s’s top line has witnessed a three-year (2013–16) compound annual growth rate (CAGR) of 9.5%. This consistent revenue growth primarily has been driven by its rapidly growing interest income as well as inorganic growth strategies. Synchrony Financial’s revenues are primarily generated from the credit products, which make its growth dependent on the ability to retain existing partners and attract new partners.
The company has been witnessing substantial inorganic growth since 2013, the year of its inception. Its CareCredit unit acquired the Citi Health Card portfolio to further expand its healthcare acceptance network in the United States. A major mention here is the buyout of GPShopper that created new mobile solutions for Synchrony Financial’s retail partners.
CareCredit has been significantly contributing to the company’s growth. Being a leading provider of promotional financing to consumers for health and personal care procedures, products or services, this unit has seen steep increase in interest and fees on loans which aided to the company’s overall top-line growth.
Synchrony Financial’scontinuous investment in technology in order to upgrade its offerings has helped it establish a strong position in the market. Even during the first quarter of 2017, Synchrony Financial launched Cathay Pacific program and Synchrony Car CareTM credit card to increase customer engagement in its offerings.
Its consistent cash flow generation supports capital deployment activities. Net cash from operating activities that has witnessed a three-year (2013–16) CAGR of 6.3% helped it deploy capital through share buybacks and dividend payments to enhance shareholders’ value.
The stock also seems undervalued compared to its peers. Its P/E ratio is 11.37, which although is above the midpoint of its range (11.37-14.01), compares favorably with the broader industry average of 16.47.
Despite these tailwinds, the stock has lost nearly 18% year to date, whereas the Zacks categorized Financial- Miscellaneous Services industry gained 4.6%. This underperformance has likely stemmed from higher expenses. The company has been witnessing a steep rise in its expenses since 2013, the year of its inception. Total other expenses have witnessed a three-year CAGR (2013–16) of 12.3%. In addition, increasing allowance for loan losses as well as rising fraud related loss also might have caused this underperformance
Zacks Rank and Stocks to Consider
Synchrony Financial currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the finance sector include The Progressive Corp. (PGR - Free Report) , Cigna Corporation (CI - Free Report) and FBL Financial Group, Inc. . Progressive sports a Zacks Rank #1 (Strong Buy) where as the other two stocks hold a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Progressive has delivered positive surprises in two of the last four quarters with an average beat of 4.95%.
Cigna has delivered positive surprises in three of the last four quarters with an average beat of 1.35%.
FBL Financial has delivered positive surprises in two of the last four quarters with an average beat of 1.98%.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.See Them Free>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Synchrony Financial Rides on Acquisitions, High Costs a Woe
Synchrony Financial (SYF - Free Report) offers a wide range of credit products through a diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and health and wellness providers. The company’s solid organic and inorganic strategies backed by strong financial position have paved the way for its long-term growth.
Synchrony Financial’s’s top line has witnessed a three-year (2013–16) compound annual growth rate (CAGR) of 9.5%. This consistent revenue growth primarily has been driven by its rapidly growing interest income as well as inorganic growth strategies. Synchrony Financial’s revenues are primarily generated from the credit products, which make its growth dependent on the ability to retain existing partners and attract new partners.
The company has been witnessing substantial inorganic growth since 2013, the year of its inception. Its CareCredit unit acquired the Citi Health Card portfolio to further expand its healthcare acceptance network in the United States. A major mention here is the buyout of GPShopper that created new mobile solutions for Synchrony Financial’s retail partners.
CareCredit has been significantly contributing to the company’s growth. Being a leading provider of promotional financing to consumers for health and personal care procedures, products or services, this unit has seen steep increase in interest and fees on loans which aided to the company’s overall top-line growth.
Synchrony Financial’scontinuous investment in technology in order to upgrade its offerings has helped it establish a strong position in the market. Even during the first quarter of 2017, Synchrony Financial launched Cathay Pacific program and Synchrony Car CareTM credit card to increase customer engagement in its offerings.
Its consistent cash flow generation supports capital deployment activities. Net cash from operating activities that has witnessed a three-year (2013–16) CAGR of 6.3% helped it deploy capital through share buybacks and dividend payments to enhance shareholders’ value.
The stock also seems undervalued compared to its peers. Its P/E ratio is 11.37, which although is above the midpoint of its range (11.37-14.01), compares favorably with the broader industry average of 16.47.
Despite these tailwinds, the stock has lost nearly 18% year to date, whereas the Zacks categorized Financial- Miscellaneous Services industry gained 4.6%. This underperformance has likely stemmed from higher expenses. The company has been witnessing a steep rise in its expenses since 2013, the year of its inception. Total other expenses have witnessed a three-year CAGR (2013–16) of 12.3%. In addition, increasing allowance for loan losses as well as rising fraud related loss also might have caused this underperformance
Zacks Rank and Stocks to Consider
Synchrony Financial currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the finance sector include The Progressive Corp. (PGR - Free Report) , Cigna Corporation (CI - Free Report) and FBL Financial Group, Inc. . Progressive sports a Zacks Rank #1 (Strong Buy) where as the other two stocks hold a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Progressive has delivered positive surprises in two of the last four quarters with an average beat of 4.95%.
Cigna has delivered positive surprises in three of the last four quarters with an average beat of 1.35%.
FBL Financial has delivered positive surprises in two of the last four quarters with an average beat of 1.98%.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>